Example: Heart Attack

Clinical Trials on Autoimmune Hemolytic Anemia

Total 40 results

NCT03538041

Recruiting

A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia

Conditions: Autoimmune Hemolytic Anemia
NCT04256148

Withdrawn

ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia

Conditions: Warm Autoimmune Hemolytic Anemia
NCT04138927

Active, not recruiting

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Conditions: Warm Antibody Autoimmune Hemolytic Anemia
NCT04119050

Recruiting

Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

Conditions: Warm Autoimmune Hemolytic Anemia
NCT04024202

Recruiting

Data Registry of Auto Immune Hemolytic Anemia

Conditions: Autoimmune Hemolytic Anemia
NCT02612558

Active, not recruiting

A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)

Conditions: Warm Antibody Autoimmune Hemolytic Anemia
NCT02158195

Unknown status

Immunopathology of Autoimmune Hemolytic Anemia

Conditions: Autoimmune Hemolytic Anemia
NCT03269292

Completed

Clinical Characteristics and Treatment Outcomes of Patients With Autoimmune Hemolytic Anemia

Conditions: Autoimmune Hemolytic Anemia
NCT02828670

Recruiting

Role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia (TFH in AIHA)

Conditions: Autoimmune Hemolytic Anemia
NCT04661033

Not yet recruiting

Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia

Conditions: Warm Autoimmune Hemolytic Anemia
NCT04083014

Recruiting

Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia

Conditions: Autoimmune Hemolytic Anemia; Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
NCT04253236

Suspended

To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA).

Conditions: Warm Autoimmune Hemolytic Anemia
NCT03075878

Terminated

A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA)

Conditions: Warm Autoimmune Hemolytic Anemia
NCT01181154

Completed

Rituximab in Auto-Immune Hemolytic Anemia

Conditions: Warm Autoimmune Hemolytic Anemia
NCT03827603

Active, not recruiting

Ibrutinib in Steroid Refractory Autoimmune Hemolytic Anemia

Conditions: AIHA - Warm Autoimmune Hemolytic Anemia
NCT04691570

Not yet recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Subjects With Warm Autoimmune Hemolytic Anemia (wAIHA)

Conditions: Warm Autoimmune Hemolytic Anemia (wAIHA)
NCT03226678

Active, not recruiting

Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)

Conditions: Warm Autoimmune Hemolytic Anemia; Cold Agglutinin Disease
NCT03764618

Recruiting

A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA

Conditions: Warm Antibody Autoimmune Hemolytic Anemia
NCT04398459

Recruiting

The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia

Conditions: Refractory/Relapsed Autoimmune Hemolytic Anemia
NCT04657094

Recruiting

Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia

Conditions: Autoimmune Hemolytic Anemia; Chronic Lymphocytic Leukemia; Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Warm Antibody Autoimmune Hemolytic Anemia
NCT02389231

Completed

Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment

Conditions: Autoimmune Hemolytic Anemia
NCT04039477

Withdrawn

A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP

Conditions: Autoimmune Hemolytic Anemia; Immune Thrombocytopenia
NCT01579110

Unknown status

Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.

Conditions: Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Hemolysis; Hematologic Diseases; Autoimmune Diseases; Immune System Diseases; Pathologic Processes
NCT01345708

Completed

A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia

Conditions: Autoimmune Hemolytic Disease (Cold Type) (Warm Type)
NCT02877706

Recruiting

Autoimmune Cytopenias : Midi-Pyrenees Registry

Conditions: Immune Thrombocytopenia; Autoimmune Hemolytic Anemia